Disease specificity of nondefective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides
about
ALY is a common coactivator of RUNX1 and c-Myb on the type B leukemogenic virus enhancerVirological events leading to spontaneous AKR thymomasOrigins of enhancer sequences of recombinant murine leukemia viruses from spontaneous B- and T-cell lymphomas of CWD mice.Influence of enhancer sequences on thymotropism and leukemogenicity of mink cell focus-forming viruses.Pathogenic and host range determinants of the feline aplastic anemia retrovirus.Sequence-specific and/or stereospecific constraints of the U3 enhancer elements of MCF 247-W are important for pathogenicity.Tandemization of a subregion of the enhancer sequences from SRS 19-6 murine leukemia virus associated with T-lymphoid but not other leukemias.In vivo footprinting of the enhancer sequences in the upstream long terminal repeat of Moloney murine leukemia virus: differential binding of nuclear factors in different cell typesSequences between the enhancer and promoter in the long terminal repeat affect murine leukemia virus pathogenicity and replication in the thymus.Feline leukemia virus long terminal repeat activates collagenase IV gene expression through AP-1Core-binding factor influences the disease specificity of Moloney murine leukemia virusEnv-derived gp55 gene of Friend spleen focus-forming virus specifically induces neoplastic proliferation of erythroid progenitor cells.Identification of genetic determinants responsible for the rapid immunosuppressive activity and the low leukemogenic potential of a variant of Friend leukemia virus, FIS-2.Envelope is a major viral determinant of the distinct in vitro cellular transformation tropism of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2.Analysis of the disease potential of a recombinant retrovirus containing Friend murine leukemia virus sequences and a unique long terminal repeat from feline leukemia virusEnhancer sequences of a retroviral vector determine expression of a gene in multipotent hematopoietic progenitors and committed erythroid cells.Sequence analysis of porcine endogenous retrovirus long terminal repeats and identification of transcriptional regulatory regionsIdentification of homeodomain proteins, PBX1 and PREP1, involved in the transcription of murine leukemia virus.Selection for c-myc integration sites in polyclonal T-cell lymphomas.Insertional mutagenesis and deep profiling reveals gene hierarchies and a Myc/p53-dependent bottleneck in lymphomagenesis.Characterization of nuclear protein binding to a site in the long terminal repeat of a murine leukemia virus: comparison with the NFAT complex.Function of a unique sequence motif in the long terminal repeat of feline leukemia virus isolated from an unusual set of naturally occurring tumors.E- vectors: development of novel self-inactivating and self-activating retroviral vectors for safer gene therapy.Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells.Human T-cell lymphotropic virus type 1 Tax mediates enhanced transcription in CD4+ T lymphocytesStability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants.Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.The feline leukemia virus long terminal repeat contains a potent genetic determinant of T-cell lymphomagenicityInducible and cell type-specific expression of VL30 U3 subgroups correlate with their enhancer design.Identification of human T-cell lymphotropic virus type I 21-base-pair repeat-specific and glial cell-specific DNA-protein complexesIdentification of a region of a murine leukemia virus long terminal repeat with novel transcriptional regulatory activitiesMolecular cloning and characterization of an immunosuppressive and weakly oncogenic variant of Friend murine leukemia virus, FIS-2The R-U5-5' leader sequence of neurovirulent wild mouse retrovirus contains an element controlling the incubation period of neurodegenerative diseaseNuclear factor 1 activates the feline leukemia virus long terminal repeat but is posttranscriptionally down-regulated in leukemia cell linesTwo factors that bind to highly conserved sequences in mammalian type C retroviral enhancers.Characterization of a protein that binds multiple sequences in mammalian type C retrovirus enhancers.A protein-binding site with dyad symmetry in the long terminal repeat of the MCF13 murine leukemia virus that contributes to transcriptional activity in T lymphocytes.Contributions to transcriptional activity and to viral leukemogenicity made by sequences within and downstream of the MCF13 murine leukemia virus enhancer.Mechanism of leukemogenesis induced by mink cell focus-forming murine leukemia viruses.Molecular characterization of a neuropathogenic and nonerythroleukemogenic variant of Friend murine leukemia virus PVC-211
P2860
Q24672313-54936575-A345-4585-A492-E7CAF3731837Q28279811-E88B5A15-CFA8-4BD3-A996-1B3D2AB6923AQ30452120-0C2B7A54-7633-44C1-9E55-F2FB6F8843B8Q30452207-93AF2115-F4EE-4DE4-8AA6-297D47BF6469Q33567475-0C22808A-6E27-4E32-9BB7-ACA13717F720Q33639086-A5E29B2F-FB6A-4B70-9965-F6C92618351AQ33648866-5A366238-5CE5-4BC7-A1ED-1D929D7C2CFDQ33785327-43AB2224-398C-4158-9B0E-BF01A10F9BB8Q33814017-10509C91-48F3-4D39-AF4C-92FCCC8087EFQ33814106-EB4883C7-69CB-4BBE-8321-B93FC4616031Q33815221-6391F710-A93A-45E6-A0A4-FCE3B00D4FD6Q33920536-06C0A6AF-81BD-4F1C-9E82-71E508C0A147Q34069593-6CEE21FB-B940-477B-9855-91B48E91B65BQ34142780-A3CBFA64-AF43-4F63-8FE5-F986520520EAQ34328436-31E04426-3996-464D-A72B-2DFB6875F478Q34373796-E1D4B601-451C-4049-BA77-7DB8F5E938CFQ34462379-ED10B59C-0733-4990-BFE3-E9A382350BC1Q34463374-C59BE4A3-8AAD-4CC5-B72C-15192DC2450FQ34970423-75B3EEDB-59F2-416E-8FA3-AB3CBF0F8006Q35105746-DA3A835D-EB79-48A7-A829-7557A86117FDQ35832136-9604E531-B96F-4D14-9711-1CD8866AD87DQ35839448-3F7C6169-75BB-4B28-A4C0-C794BBCF4A9AQ35850215-5F09E35E-8206-46F9-BAB6-4C5BCB32E1D5Q35851842-FDF3C78E-ED3A-4FE2-B400-8D441D5A59BAQ35858230-24D0325D-4DC8-4624-959E-367564865BF9Q35887850-E9879F2F-E289-4260-8993-0319DF0FBE11Q35894998-1AFB407E-9C83-4780-B9D5-8DBD66758747Q36549315-502CFC7C-6F6E-48DD-8A45-3D3CA21260D3Q36619591-C2D6E6D0-FD9E-4FEE-924C-D0C0DDAF3826Q36622932-0EAAF56E-7AB2-4D85-B5AC-A5F83F0BA730Q36633701-D8B50229-9F2B-4563-BB16-F81A00C4F101Q36636839-6494CC27-62D7-4D93-820E-7DEB0F3AA70EQ36683978-2CB4E9C6-A397-49DD-9F1C-A90511FA3A45Q36684305-14D69F63-58AB-4543-AB9B-05AEEF631151Q36686005-3BD9B04D-8201-4906-B61E-D8640DB0801EQ36686016-D5F8EAE5-5DE9-4F10-B153-AC6E9AAC7766Q36686850-8C5F39F5-58F9-48EC-B3EA-F85510980BF6Q36686893-150FEF18-6552-4DEE-B57E-E03DE0EBF73FQ36688798-D3976196-6DB0-4EF7-A167-5ADC7B8CB8E4Q36697287-0700491C-01BF-4868-A9F3-E38BB0C701E2
P2860
Disease specificity of nondefective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Disease specificity of nondefe ...... a small number of nucleotides
@en
type
label
Disease specificity of nondefe ...... a small number of nucleotides
@en
prefLabel
Disease specificity of nondefe ...... a small number of nucleotides
@en
P2093
P2860
P1433
P1476
Disease specificity of nondefe ...... a small number of nucleotides
@en
P2093
P2860
P304
P407
P577
1987-03-01T00:00:00Z